Clinical Trial Update: Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection [Phase 2]

View source ↗

Summary

Phase 2 trial investigating modulation of cellular stress in immune cells to reduce symptomatic viral infections; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endoplasmic Reticulum Stress-related Disorders
• Viral Infection

Snippet

Sponsor: Singapore General Hospital | Conditions: Endoplasmic Reticulum Stress, Viral Infection | Phase 2 | Status: COMPLETED